MultiMedRx vs Trava Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MultiMedRx

Provider comparison

Patients comparing four-week compounded plans who want named providers and can confirm state availability and the full checkout total.

Semaglutide / month: $199 per 4 weeksRegular compounded plan; $139 introductory first cycle
Tirzepatide / month: $299 per 4 weeksRegular compounded plan; $179 introductory first cycle

Index 64/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check MultiMedRx pricing Read review

Trava Health

Provider comparison

Shoppers who verify the actual quoted price and their state's eligibility directly at checkout before trusting the homepage banner.

Semaglutide / month: $117.96/moStarting dose, monthly plan, compounded; quarterly package costs less per month
Tirzepatide / month: $178.98/moStarting dose, monthly plan, compounded; quarterly package costs less per month

Index 63/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Trava Health pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

MultiMedRx has the higher Cost-Efficiency Index: 64/100 versus 63/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

MultiMedRx: Coverage not published
Trava Health: Confirm availability in your state before paying

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MultiMedRx

Trava Health

Semaglutide / month: MultiMedRx: $199 per 4 weeksRegular compounded plan; $139 introductory first cycle; Trava Health: $117.96/moStarting dose, monthly plan, compounded; quarterly package costs less per month

Tirzepatide / month: MultiMedRx: $299 per 4 weeksRegular compounded plan; $179 introductory first cycle; Trava Health: $178.98/moStarting dose, monthly plan, compounded; quarterly package costs less per month

Semaglutide / year (modeled): MultiMedRx: $2,58713 charges; Trava Health: $1,416

Tirzepatide / year (modeled): MultiMedRx: $3,88713 charges; Trava Health: $2,148

State availability: MultiMedRx: Coverage not published; Trava Health: Confirm availability in your state before paying

Oral / sublingual option listed: MultiMedRx: Not listed; Trava Health: Not listed

Brand-name access listed: MultiMedRx: Yes; Trava Health: Not confirmed

Provider facts checked: MultiMedRx: October 2026; Trava Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MultiMedRx

Patients comparing four-week compounded plans who want named providers and can confirm state availability and the full checkout total.

Reasons to consider it

Publishes regular four-week prices of $199 semaglutide and $299 tirzepatide
Names Adam Mizeracki, MD and Jennifer Faggionato, PA
Also offers brand-name Wegovy and Zepbound prescriptions

What to weigh up

Introductory $139/$179 figures apply only to the first cycle
Lower six-month rates require prepayment
The FAQ caps included medication volume; ask how higher doses affect the total

Compounded drugs are not FDA-approved. Understand the medication options.

Check MultiMedRx pricing Read the full MultiMedRx review

Trava Health

Shoppers who verify the actual quoted price and their state's eligibility directly at checkout before trusting the homepage banner.

Reasons to consider it

Transparent quarterly-package discount is disclosed in dollar terms, not just a vague percentage
HSA/FSA eligible
Named legal entity and Houston, TX address disclosed in the Terms of Service

What to weigh up

The $88.65 semaglutide figure is a quarterly-plan monthly equivalent; the monthly starting price is $117.96
State availability is not listed in the public FAQ; confirm eligibility before paying
Starting-dose prices do not establish what your maintenance dose will cost

Compounded drugs are not FDA-approved. Understand the medication options.

Check Trava Health pricing Read the full Trava Health review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MultiMedRxTrava Health

Normalized Cost/Month: MultiMedRx:
66/100; Trava Health:
76/100

Price Transparency: MultiMedRx:
86/100; Trava Health:
78/100

Nationwide Access: MultiMedRx:
24/100; Trava Health:
24/100

Formulation Options: MultiMedRx:
79/100; Trava Health:
66/100

Clinical Oversight: MultiMedRx:
78/100; Trava Health:
77/100

Contract Flexibility: MultiMedRx:
49/100; Trava Health:
55/100

Before you sign up

Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to MultiMedRx Alternatives to Trava Health

More provider matchups

CoreAge Rx vs MultiMedRx CoreAge Rx vs Trava Health

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.